Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System
Cleaning Validation

Cleaning Validation

View Detailed Analysis

Analytics Overview

111
Form 483s Issued
16
483s converted to WL
155
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Nov 2024
Dr. Reddy's Laboratories Limited (Unit II)
Drugs
27 Sep 2024
Brookfield Medical Surgical Supply, Inc.
Drugs
20 Sep 2024
Aarti Drugs Limited
Drugs
06 Sep 2024
Granules India Limited
Drugs
06 Sep 2024
Granules India Limited
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Justin A Boyd
19
2
Anastasia M Shields
12
2
Jonah S Ufferfilge
7
0
Joseph A Piechocki
6
0
Arsen Karapetyan
6
1
TITLE/ COMPANY Issue Date Status Details
Equipment and utensils were not cleaned, maintained, and sanitized at appropriate intervals to prevent malfunctions and contamination
Dr. Reddy's Laboratories Limited (Unit II)
19 Nov 2024 Normal Justification: Cleaning validation is directly linked as there's a failure to conduct necessary validations for equipment cleaning.
Excerpt: You established a campaign cleaning frequency...without performing any cleaning validation...
View Details
Your firm failed to appropriately clean equipment located in the ISO 5 area.
Brookfield Medical Surgical Supply, Inc.
27 Sep 2024 Normal Justification: Cleaning Validation is directly compromised due to failure to execute required cleaning protocol after a contamination event.
Excerpt: Your firm failed to perform a (b) (4) clean after ... an objectionable organism identified.
View Details
Written procedures are not established for cleaning of equipment and its subsequent release for use
Aarti Drugs Limited
20 Sep 2024 Normal Justification: Cleaning Validation is directly connected as the primary issue is with validation of cleaning methods and evidence.
Excerpt: Your firm has not established adequate cleaning validation for your equipment located in Plant and (b) Plant (4) used in the production of the APIs for the U.S. market.
View Details
Building and facilities are not maintained to ensure that products manufactured meet the quality
Granules India Limited
06 Sep 2024 Normal Justification: Observation highlights visible contamination and microbial growth which suggests failures in cleaning validation.
Excerpt: Swab analyses test results revealed presence of drug substances... and colonies of bacterial and yeast.
View Details
Building and facilities are not maintained to ensure that products manufactured meet the quality, purity characteristics
Granules India Limited
06 Sep 2024 Normal Justification: Cleaning validation ensures the removal of potential contaminants, critical for product safety.
Excerpt: APUs, AHUs, and equipment covered with apparent off-white to white powdery materials and dust.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.